Medical Marijuana Inc.’s HempMedsPX Expands Sales Efforts Based on PhytoSPHERE Systems 1,500% Increase in Industrial Hemp Cannabidiol (CBD) Oil Production

Production Capabilities of Award-Winning CBD-Rich Hemp Oil Scales Up to Address Growing Global Demand

SAN DIEGO, Feb. 5, 2014 (GLOBE NEWSWIRE) — Medical Marijuana Inc. (OTC Pink:MJNA) would like to inform shareholders and the general public that HempMedsPX™ – a corporate portfolio company of Medical Marijuana Inc. and the exclusive master distributor and contracted marketing company for CannaVest Corp. and Medical Marijuana Inc. – is actively expanding global sales based on CannaVest Corp. (OTC:CANV)’s subsidiary, PhytoSPHERE Systems’ 1,500% increase in production capability for industrial hemp-based cannabidiol (CBD) oil. PhytoSPHERE’s San Diego laboratory houses specialized equipment for high pressure processing of the world’s most abundant source of industrial hemp-based CBD oil.

“Being the world’s first industrial hemp-based CBD oil provider is one thing. Scaling to meet growing global market demand for hemp-based CBD oil products requires an entirely different set of dynamics,” states Michelle Sides, COO of Medical Marijuana Inc. “A significant benefit to Medical Marijuana Inc. is PhytoSPHERE’s innovative team of scientists who bring their knowledge and passion to the development of all-natural industrial hemp-based CBD oil products that consumers are demanding worldwide. PhytoSPHERE’s state-of-the-art laboratory and world-class staff are responsible for the consistency in product volume and quality that our customers trust. This abundance of CBD-rich hemp oil allows HempMedsPX to be a trailblazer providing consistently high-quality CBD-rich hemp oil nutritional supplements, personal care and lifestyle products to distributors and consumers around the world.”

The product that the world is in awe over is known as “CBD Simple.” This record-breaking prototype 96%+/- CBD extract (which is not available to the public) was developed by PhytoSPHERE’s world-class team of scientists, including:

Josh Hartsel, Ph.D, Senior Research Scientist
Greg Waterbury, Project Manager
Ryan Lamer, Chemist
CBD Simple won the 2013 High Times Cannabis Cup competition in Amsterdam for Highest CBD Concentrate. This international judging event featured entries by the most prominent growers, breeders and producers of cannabis and cannabis products worldwide. CBD Simple also won the 2013 Seattle High Times Cannabis Cup and 2013 Michigan Medical Marijuana Conference “Green Cup” contests for Highest CBD Concentrate.

With increased production, an increase in quality control (QC) and quality assurance (QA) are required to produce a consistent product. Each of the product runs are lab tested for purity. In addition to CBD Simple, PhytoSPHERE is responsible for developing hemp CBD-rich product formulations including:

Real Scientific Hemp Oil (RSHO)™ — The world’s most concentrated form of industrial hemp-based CBD nutritional supplement.

Cibdex™ — An everyday CBD-rich hemp oil supplement available in 100mg and 500mg tinctures in original and peppermint flavors as well as non-flavored 25mg vegan capsules.

These are all unique, all-natural, non-GMO, generational grown CBD-rich hemp oil product lines represented, marketed and distributed by HempMedsPX™. For more information or to purchase these products visit:


Real Scientific Hemp Oil™

About HempMedsPX

HempMedsPX offers mainstream marketing, sales, customer service, and logistics for the cannabis industry. HempMedsPX is a corporate portfolio company of Medical Marijuana, Inc. (OTC Pink:MJNA) and the exclusive master distributor and contracted marketing company for CannaVest Corp. (OTC:CANV) and Medical Marijuana Inc. In addition to handling sales and distribution, HempMedsPX is the communication hub for the Medical Marijuana Inc. portfolio of companies.

About CannaVest Corp.

CannaVest Corp. is in the business of investing and developing hemp-based businesses. CannaVest Corp. also develops, produces, markets and sells end-consumer products to the nutraceutical industry containing the hemp plant extract, cannabidiol (CBD). Additionally, the company resells—to third parties—raw product acquired by CannaVest Corp. pursuant to the company’s supply international relationships.CannaVest Corp. seeks to take advantage of an emerging worldwide trend to re-energize the production of industrial hemp and to foster its many uses for consumers. Cannabinoids (cannabidiol/CBD) are natural constituents of the hemp plant, and CBD is derived from hemp stalk and seed. Additional information is available from or by visiting

About PhytoSPHERE Systems

PhytoSPHERE Systems is a global phytocannabinoid biotechnology company based in San Diego, California with an exclusive license for use by CannaVest Corp. (OTC:CANV). The company utilizes advanced cultivation methods and state-of-the-art processing technology leading to development of pharmaceutical, nutraceutical, and food products.

PhytoSPHERE Systems, the manufacturer of the CBD-rich hemp oil used in Real Scientific Hemp Oil (RSHO), has developed special cultivars (similar to “strains”) that produce hemp that is especially rich in CBD, making it possible for PhytoSPHERE to offer all-natural products with high concentrations of hemp-based CBD. For more information, visit:


These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.


This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.


Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp-based products and are involved with Federally Legal Distribution of Medical Marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.

For further information, please contact:

Investor relations contact:
Stuart T. Smith
SmallCapVoice.Com, Inc.
P. 512-267-2430

Corporate Contact:

Medical Marijuana, Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)